Clinical Trials in Pennsylvania

Showing 11861-11880 of 16,895 trials

A Study to Evaluate the Safety and Efficacy of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)

NCT02678793

Subjects who have completed study 4975-MN-202 will be eligible to receive open-label treatment with CNTX-4975 200 µg in study 4975-MN-203 if they meet the inclusion/exclusion criteria.

Morton's Neuroma

Centrexion Therapeutics67 participantsStarted Dec 2015

Phoenix, Arizona, United States • Jonesboro, Arkansas, United States • El Cajon, California, United States +7 more locations

COMPLETEDPhase 237 miles

Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer

NCT01091454

This phase II trial studies how well brostallicin and cisplatin work in treating patients with breast cancer that has spread to other parts of the body (metastatic) and does not have estrogen receptors, progesterone receptors, or large amounts of human epidermal growth factor receptor 2 (HER2) on its cells (triple-negative). Drugs used in chemotherapy, such as brostallicin and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from spreading.

Triple-negative Breast Cancer

Alliance for Clinical Trials in Oncology48 participantsStarted Jun 2010

Scottsdale, Arizona, United States • Aurora, Colorado, United States • Boulder, Colorado, United States +263 more locations

A Study to Evaluate the Safety and Efficacy of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)

Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer

Find Trials by Condition in Pennsylvania

Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme

Bevacizumab and Temozolomide or Bevacizumab and Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed by Surgery

A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response

Multiple Ascending Dose Study of PRX003 in Subjects With Psoriasis

A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate

A Study of Daclatasvir and Sofosbuvir With Ribavirin in Subjects With Cirrhosis and Genotype 3 Hepatitis C Infection

Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773

Safety and Efficacy of Combination Listeria/GVAX Immunotherapy in Pancreatic Cancer

Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)

Efficacy and Safety of Intravenous Neridronic Acid in CRPS-I

Eating Disorders Programs: An Indicated Trial

A Study to Compare a New Long-Acting Insulin (LY2605541) and Human Insulin NPH in Participants With Type 2 Diabetes

LINX Reflux Management System Clinical Study Protocol

Safety and Efficacy Study of NP001 in Patients With Amyotrophic Lateral Sclerosis (ALS) and Systemic Inflammation

The EMPrint™ Ablate and RESect Study in Patients With Metastatic Lung Tumors (EMPRESS)

International Diabetes Closed Loop (iDCL) Trial: Research Site Training Protocol

Double-Blind, Multi-Center, Randomized Study to Assess the Efficacy and Safety of Velneperit (S-2367) and Orlistat Administered Individually or Combined With a Reduced Calorie Diet (RCD) in Obese Subjects

The Effect Of NS-0200 Versus Placebo On Hepatic Fat Content In Patients With Non Alcoholic Fatty Liver Disease